NUVB
Nuvation Bio Inc. NYSE Listed Aug 26, 2020$5.74
+0.17%
vs $5.73
Mkt Cap $2.0B
52w Low $3.00
40.6% of range
52w High $9.75
50d MA $6.42
200d MA $5.86
P/E (TTM)
—
EV/EBITDA
—
P/B
6.4x
Debt/Equity
0.0x
ROE
-66.9%
P/FCF
-11.3x
RSI (14)
25.80
ATR (14)
$0.28
Beta
1.61
50d MA
$6.42
200d MA
$5.86
Avg Volume
5.2M
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that epigenetically regulates proteins that control tumor growth and differentiation; NUV-569, a differentiated oral small molecule selective inhibitor of the Wee1 kinase for DNA damage repair; NUV-1182, an adenosine receptor inhibitor; and drug-drug conjugate (DDC) platform that focuses on targeting an inhibitor of poly ADP ribose polymerase (PARP) to anti-cancer warheads of existing drugs, as well as PARP inhibitor to address ER+ breast and ovarian cancer. The company was formerly known as RePharmation Inc. and changed its name to Nuvation Bio Inc. in April 2019. Nuvation Bio Inc. was founded in 2018 and is headquartered in New York, New York.
1500 Broadway · New York City, NY 10036 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | AMC | -0.14 | -0.15 | -5.9% | 6.11 | +3.1% | +8.0% | +0.0% | -3.5% | +0.8% | -5.0% | — |
| May 4, 2026 | AMC | -0.03 | 0.01 | +135.5% | 4.41 | -0.9% | +9.5% | +4.3% | -4.6% | -0.4% | -0.6% | — |
| Mar 2, 2026 | AMC | -0.11 | -0.11 | +0.0% | 5.84 | -17.6% | -25.3% | +8.7% | -3.6% | +0.4% | +3.1% | — |
| Nov 3, 2025 | AMC | -0.17 | -0.16 | +5.9% | 5.17 | -0.4% | -6.6% | +1.9% | +2.0% | -5.8% | -1.9% | — |
| Aug 7, 2025 | AMC | -0.17 | -0.17 | +0.0% | 2.34 | +3.4% | -1.7% | -2.6% | +3.6% | +12.5% | +5.7% | — |
| May 7, 2025 | AMC | -0.16 | -0.16 | +0.0% | 2.04 | +8.8% | +2.9% | -0.5% | +2.9% | +1.9% | -0.9% | — |
| Mar 6, 2025 | AMC | -0.14 | -0.15 | -7.1% | 1.89 | +0.0% | +6.9% | -6.9% | +21.8% | -2.2% | -1.3% | — |
| Nov 6, 2024 | AMC | -0.13 | -0.15 | -15.4% | 2.54 | +1.6% | +3.1% | +9.9% | +4.5% | -2.7% | +0.7% | — |
| Aug 5, 2024 | AMC | -0.06 | -0.15 | -150.0% | 3.18 | +0.0% | -6.3% | -4.0% | +0.7% | -1.7% | -0.4% | — |
| May 14, 2024 | AMC | -0.08 | -0.07 | +12.5% | 3.30 | +3.3% | +0.0% | +3.3% | -2.6% | +4.8% | -2.3% | — |
| Feb 29, 2024 | AMC | -0.10 | -0.06 | +40.0% | 1.87 | -0.5% | +19.3% | -4.9% | +2.8% | +9.6% | +4.2% | — |
| Nov 2, 2023 | AMC | -0.10 | -0.09 | +10.0% | 1.28 | -1.6% | +5.5% | -2.2% | +1.5% | +2.2% | -9.5% | — |
| Aug 3, 2023 | AMC | -0.11 | -0.09 | +18.2% | 1.76 | +0.0% | +4.5% | +6.0% | +5.1% | +2.4% | -6.2% | — |
| May 4, 2023 | AMC | -0.09 | -0.10 | -11.1% | 1.62 | +0.0% | +3.1% | -3.0% | -0.6% | +0.0% | +0.0% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 21 | Cantor Fitzgerald | Initiates | Overweight | — | $6.83 | $6.98 | +2.2% | +1.5% | -2.5% | +5.0% | -2.0% | +0.4% |
| Aug 18 | JP Morgan | Initiates | Overweight | $13 | $6.48 | $6.57 | +1.4% | +7.4% | +4.3% | -5.9% | +1.5% | -2.5% |
| Apr 16 | Wedbush | Maintains | Outperform → Outperform | — | $4.82 | $4.88 | +1.2% | -0.2% | +5.6% | +0.8% | -0.2% | +0.2% |
| Apr 2 | Wedbush | Maintains | Outperform → Outperform | — | $4.51 | $4.46 | -1.1% | -2.2% | +0.9% | +1.3% | +0.4% | +2.2% |
| Mar 27 | Wedbush | Maintains | Outperform → Outperform | — | $4.42 | $4.37 | -1.1% | -3.8% | -4.7% | +5.9% | +5.1% | -2.2% |
| Mar 3 | UBS | Maintains | Neutral → Neutral | — | $5.84 | $4.81 | -17.6% | -25.3% | +8.7% | -3.6% | +0.4% | +3.1% |
| Mar 3 | RBC Capital | Maintains | Outperform → Outperform | — | $5.84 | $4.81 | -17.6% | -25.3% | +8.7% | -3.6% | +0.4% | +3.1% |
| Feb 10 | Wedbush | Maintains | Outperform → Outperform | — | $5.64 | $5.67 | +0.5% | +1.2% | +0.2% | +1.2% | -0.3% | +1.9% |
| Jan 21 | RBC Capital | Maintains | Outperform → Outperform | — | $6.01 | $6.07 | +1.0% | +2.3% | -3.9% | -5.4% | -1.6% | +2.0% |
| Jan 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $8.04 | $7.69 | -4.4% | -19.7% | +1.4% | -3.7% | -2.7% | -4.7% |
| Dec 11 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $7.84 | $8.11 | +3.4% | +5.5% | +1.9% | +0.9% | +1.8% | -1.6% |
| Dec 1 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $8.03 | $7.93 | -1.2% | -1.9% | -5.2% | +12.0% | -0.7% | +2.9% |
| Nov 20 | Citizens | Maintains | Market Outperform → Market Outperform | — | $7.15 | $7.20 | +0.7% | -2.0% | -0.3% | +6.0% | +6.3% | +1.6% |
| Nov 4 | RBC Capital | Maintains | Outperform → Outperform | — | $5.17 | $5.15 | -0.4% | -6.6% | +1.9% | +2.0% | -5.8% | -1.9% |
| Nov 4 | Citizens | Maintains | Market Outperform → Market Outperform | — | $5.17 | $5.15 | -0.4% | -6.6% | +1.9% | +2.0% | -5.8% | -1.9% |
| Oct 13 | Wedbush | Maintains | Outperform → Outperform | — | $3.74 | $3.82 | +2.1% | -1.6% | -3.5% | +6.2% | -3.7% | -6.1% |
| Sep 19 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.17 | $3.22 | +1.6% | +1.6% | +1.6% | -1.5% | +0.6% | -7.1% |
| Sep 8 | Wedbush | Maintains | Outperform → Outperform | — | $3.90 | $3.82 | -2.1% | -10.5% | -4.0% | -0.9% | +0.9% | -6.3% |
| Aug 8 | RBC Capital | Maintains | Outperform → Outperform | — | $2.34 | $2.42 | +3.4% | -1.7% | -2.6% | +3.6% | +12.5% | +5.7% |
| Jun 25 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $2.05 | $2.03 | -1.0% | -8.3% | +4.8% | -2.0% | +1.0% | -0.5% |
| Jun 17 | RBC Capital | Maintains | Outperform → Outperform | — | $1.86 | $1.85 | -0.5% | -8.1% | +4.7% | +10.1% | +3.0% | +1.0% |
| Jun 11 | Wedbush | Maintains | Outperform → Outperform | — | $2.53 | $2.53 | +0.0% | -13.0% | -17.7% | -4.4% | +7.5% | -8.1% |
| Jun 2 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $2.12 | $2.17 | +2.4% | +10.4% | +4.7% | +0.0% | +1.2% | +0.0% |
| May 16 | Wedbush | Maintains | Outperform → Outperform | — | $2.24 | $2.24 | +0.0% | +0.9% | +1.8% | -5.7% | -6.5% | +10.8% |
| Mar 10 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.02 | $1.80 | -10.9% | -6.9% | +21.8% | -2.2% | -1.3% | -3.2% |
| Jan 23 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.65 | $2.69 | +1.5% | +4.5% | -9.0% | -0.8% | -2.0% | -1.2% |
| Jan 22 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.58 | $2.57 | -0.4% | +2.7% | +4.5% | -9.0% | -0.8% | -2.0% |
| Jan 7 | RBC Capital | Maintains | Outperform → Outperform | — | $2.84 | $2.96 | +4.2% | +14.4% | -7.4% | -7.6% | -4.0% | -3.0% |
| Jan 6 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.89 | $2.95 | +2.1% | -1.7% | +14.4% | -7.4% | -7.6% | -4.0% |
| Nov 7 | RBC Capital | Maintains | Outperform → Outperform | — | $2.54 | $2.58 | +1.6% | +3.1% | +9.9% | +4.5% | -2.7% | +0.7% |
| Oct 22 | Wedbush | Maintains | Outperform → Outperform | — | $2.36 | $2.36 | +0.0% | +2.1% | -3.3% | -1.3% | -3.9% | +6.3% |
| Sep 16 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.05 | $3.02 | -1.0% | +0.7% | +0.0% | -5.5% | +1.7% | -5.1% |
| Sep 11 | Wedbush | Maintains | Outperform → Outperform | — | $2.94 | $2.92 | -0.7% | +4.4% | -0.3% | -0.3% | +0.7% | +0.0% |
| Aug 6 | RBC Capital | Maintains | Outperform → Outperform | — | $3.18 | $3.18 | +0.0% | -6.3% | -4.0% | +0.7% | -1.7% | -0.4% |
| Jul 17 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.45 | $3.39 | -1.7% | -1.7% | -6.2% | -5.7% | +4.3% | +4.8% |
| Jun 3 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.10 | $3.12 | +0.6% | -12.3% | -4.0% | +7.3% | +3.9% | -4.8% |
| May 24 | Wedbush | Maintains | Outperform → Outperform | — | $3.08 | $3.10 | +0.6% | +0.0% | -3.9% | -1.4% | +2.4% | +3.7% |
| May 22 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.40 | $3.41 | +0.3% | -3.5% | -6.1% | +0.0% | -3.9% | -1.4% |
| May 15 | Wedbush | Maintains | Outperform → Outperform | — | $3.30 | $3.41 | +3.3% | +0.0% | +3.3% | -2.6% | +4.8% | -2.3% |
| Apr 17 | RBC Capital | Maintains | Outperform → Outperform | — | $2.81 | $2.93 | +4.3% | -4.3% | -4.1% | +0.8% | +3.1% | +0.0% |
| Mar 28 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.97 | $4.03 | +1.5% | -8.3% | +1.4% | -6.5% | +5.2% | -4.1% |
| Mar 27 | Jefferies | Upgrade | Hold → Buy | — | $2.88 | $3.27 | +13.5% | +37.8% | -8.3% | +1.4% | -6.5% | +5.2% |
| Mar 26 | BTIG | Upgrade | Neutral → Buy | — | $2.25 | $2.46 | +9.3% | +28.0% | +37.8% | -8.3% | +1.4% | -6.5% |
| Mar 7 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.39 | $2.41 | +0.8% | +4.2% | -2.0% | -2.0% | -2.5% | +3.4% |
| Mar 1 | Wedbush | Maintains | Outperform → Outperform | — | $1.87 | $1.86 | -0.5% | +19.3% | -4.9% | +2.8% | +9.6% | +4.2% |
| Nov 22 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.24 | $1.25 | +0.8% | +1.6% | +3.2% | -2.3% | +0.0% | +3.9% |
| Aug 21 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.68 | $1.68 | +0.0% | -1.2% | -1.2% | +1.8% | -1.8% | +0.0% |
| May 5 | RBC Capital | Maintains | Outperform → Outperform | — | $1.62 | $1.62 | +0.0% | +3.1% | -3.0% | -0.6% | +0.0% | +0.0% |
| Jan 6 | Jefferies | Downgrade | Buy → Hold | — | $2.03 | $2.00 | -1.5% | -2.0% | +2.5% | +11.3% | -3.5% | +4.6% |
| Aug 22 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.83 | $2.74 | -3.2% | +1.4% | +0.7% | +4.5% | -1.0% | -2.0% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 23, 2026 | Wentworth Kerry | CHIEF REGULATORY OFFICER | Sell | 63,000 | $6.02 | $379K | 53,000 | -10.06% | -4.58% |
| Jun 23, 2026 | Markel Stacy | CHIEF PEOPLE OFFICER | Sell | 125,000 | $6.03 | $753K | 32,591 | -10.06% | -4.58% |
| Jun 23, 2026 | Sauvage Philippe | Chief Financial Officer | Sell | 47,668 | $6.01 | $286K | 12,673 | -10.06% | -4.58% |
| Jun 9, 2026 | Mashal Robert | — | Buy | 25,000 | $4.73 | $118K | 225,000 | +3.36% | +4.32% |
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Fmr Llc | 51,989,593 | $223M | Added | Mar 2026 |
| 2 | Blackrock, Inc. | 27,630,837 | $157M | New | Jun 2026 |
| 3 | Decheng Capital Llc | 25,954,439 | $111M | — | Mar 2026 |
| 4 | Laurion Capital Management Lp | 7,852,638 | $70M | Reduced | Dec 2025 |
| 5 | Vanguard Capital Management Llc | 11,919,514 | $68M | Added | Jun 2026 |
| 6 | Tang Capital Management Llc | 3,857,457 | $35M | Reduced | Dec 2025 |
| 7 | Duquesne Family Office Llc | 4,539,800 | $26M | — | Jun 2026 |
| 8 | Morgan Stanley | 2,552,256 | $23M | Reduced | Dec 2025 |
| 9 | Citadel Advisors Llc | 3,976,660 | $23M | Reduced | Jun 2026 |
| 10 | Vanguard Portfolio Management Llc | 2,688,666 | $15M | Added | Jun 2026 |
| 11 | Bank Of America Corp /de/ | 3,219,826 | $14M | Added | Mar 2026 |
| 12 | Aqr Capital Management Llc | 2,356,429 | $13M | Added | Jun 2026 |
| 13 | Connor, Clark & Lunn Investment Management Ltd. | 1,756,820 | $10M | Added | Jun 2026 |
| 14 | Qube Research & Technologies Ltd | 2,042,312 | $9M | Added | Mar 2026 |
| 15 | Northern Trust Corp | 2,003,108 | $9M | Added | Mar 2026 |
| 16 | Algert Global Llc | 1,842,078 | $8M | Added | Mar 2026 |
| 17 | Renaissance Technologies Llc | 1,345,995 | $8M | Added | Jun 2026 |
| 18 | Abrams Capital Management, L.p. | 1,270,504 | $7M | — | Jun 2026 |
| 19 | Two Sigma Investments, Lp | 1,248,409 | $7M | Reduced | Jun 2026 |
| 20 | D. E. Shaw & Co., Inc. | 1,140,000 | $6M | Added | Jun 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$1.99B
Enterprise Value
$1.43B
P/E (TTM)
—
Forward P/E
—
PEG Ratio
0.21x
P/B
6.41x
P/S
11.73x
P/FCF
-11.28x
EV/EBITDA
—
Shares Out
341.5M
Financials (TTM)
Revenue
$169.9M
Net Income
-$149.8M
EBITDA
-$127.0M
Free Cash Flow
-$173.8M
Op Cash Flow
-$173.4M
EPS Basic
$-0.60
EPS Diluted
$-0.44
EPS Forward
$-0.42
Gross Margin
93.9%
Op Margin
-81.0%
Net Margin
-88.2%
Balance Sheet
Total Assets
$594.8M
Total Liab.
$289.1M
Total Equity
$305.7M
Cash
$529.2M
LT Debt
$2.5M
Book Value/Sh
$0.90
Debt/Equity
0.03x
Current Ratio
6.95
Quick Ratio
6.81
Returns & Growth
ROE
-66.9%
ROA
-34.4%
ROIC
-41.0%
Rev Growth YoY
+699.0%
EPS Growth YoY
+71.6%
Price Returns
2W
-5.4%
1M
-17.5%
3M
+1.6%
6M
+29.9%
12M
+79.4%
Technicals
52W High
$9.75
52W Low
$3.00
50d MA
$6.42
200d MA
$5.86
RSI (14)
25.80
ATR (14)
$0.28
Beta
1.61
Avg Volume
5.2M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$12.40
High
$17.00
Low
$10.00
Median
$12.00
Data updated apr 26, 2026 4:10pm
· Source: financialmodelingprep.com